[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Vistra Corp. (VST) Form 144 notice: The filer reports a proposed sale of 21,371 shares of common stock to be executed through Fidelity Brokerage Services on 10/02/2025, with an aggregate market value of $4,361,025.77. The filing states there are 338,820,324 shares outstanding. The securities were acquired pursuant to an option granted on 04/09/2018 and the planned disposition indicates cash payment on the sale date. The notice also lists multiple prior sales by James A. Burke between 09/10/2025 and 10/01/2025, showing repeated common-stock dispositions and corresponding gross proceeds by date.

Positive

• Notice filed under Rule 144 demonstrating compliance with resale disclosure requirements
• Transaction routed through a registered broker (Fidelity Brokerage Services), indicating orderly execution
• Acquisition method disclosed (option granted 04/09/2018), providing transparency on insider holdings

Negative

• None.

Insights

Securities Analyst

TL;DR Insider plans a small sale relative to shares outstanding and previously executed daily sales in September.

The filing documents a proposed sale of 21,371 common shares valued at $4.36 million to occur on 10/02/2025, acquired under an option granted in 2018. The position size is immaterial relative to the reported 338.8 million shares outstanding, suggesting limited direct market-impact or dilution from this single transaction. The detailed list of prior daily sales by James A. Burke in September shows ongoing liquidity events rather than a single block sale. This is a routine insider disposition notice under Rule 144 designed to comply with resale requirements.

Corporate Governance Expert

TL;DR The filing is a routine compliance disclosure showing periodic insider sales, without disclosed material nonpublic information.

The form includes the seller's representation that no material nonpublic information is known. The securities were obtained via an option and the sale is to be executed through a broker, consistent with typical governance and disclosure practices. The chronology of multiple sales over successive trading days indicates a staged disposition likely planned to comply with Rule 144 and trading protocols. No governance red flags or unusual plan-adoption details are provided in the notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21371	4361025.77	338820324	10/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	Option Granted 04/09/2018	Issuer			21371	10/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/15/2025	21362	4481773.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/16/2025	21358	4565882.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/17/2025	21361	4540506.03
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/18/2025	21366	4554708.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/19/2025	21360	4517570.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/22/2025	21362	4503715.06
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/23/2025	21360	4490151.57
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/24/2025	21371	4355909.13
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/25/2025	21379	4273632.11
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/26/2025	21376	4300490.42
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/29/2025	21378	4316995.04
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/30/2025	19596	3905511.14
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	10/01/2025	19605	3818705.55

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Vistra Corp.'s (VST) Form 144 report?

The form reports a proposed sale of 21,371 common shares through Fidelity on 10/02/2025 valued at $4,361,025.77.

Who sold shares in the recent disclosures?

The filing lists prior sales by James A. Burke between 09/10/2025 and 10/01/2025 and the proposed sale associated with the Form 144.

How many Vistra shares are outstanding according to the filing?

The document states there are 338,820,324 shares outstanding.

How were the shares being sold originally acquired?

The securities were acquired via an option granted on 04/09/2018 and the proposed sale indicates cash payment.

What is the broker and exchange for the planned sale?

The sale is to be executed through Fidelity Brokerage Services LLC and listed as occurring on the NYSE.

Does the filing indicate any material nonpublic information?

The signee represents they do not know any material adverse information about the issuer that has not been publicly disclosed.